Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced it will provide a program update on its first-in ...

- Results highlight ATNM-400's potential as a transformative therapeutic option for prostate cancer patients with unmet clinical needs as expression of the target receptor for ATNM-400 persists ...

Actinium Pharmaceuticals (ATNM) is a cancer-focused biotech that is fundamentally misunderstood due to a perfect storm of "valuation limiting" factors that provide a classic low risk/high reward ...

Actinium Pharmaceuticals (ATNM) closed at $0.59 in the latest trading session, marking a -1.67% move from the prior day. This move lagged the S&P 500's daily gain of 0.36%. Elsewhere, the Dow gained 0 ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

Actinium Pharmaceuticals (ATNM) has delivered a -18.180% change over the past year, with a 52-week range between 0.952 and 1.945. What Is the Average Daily Trading Volume of Actinium Pharmaceuticals ...

Actinium Pharmaceuticals (ATNM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company ...

Shares of Actinium Pharmaceuticals ATNM were up 24% on Tuesday after management announced that ATNM has entered into a license and supply agreement with Sweden-based Immedica BioPharma for its most ...

--Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, today announced preclinical results with ATNM-400 in prostate cancer models presented at the American ...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than ...